HCV-Smoking Cessation Study

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 23, 2020

Primary Completion Date

November 11, 2021

Study Completion Date

November 11, 2021

Conditions
Hepatitis CSmoking Cessation
Interventions
BEHAVIORAL

Cognitive Behavioral Counseling

The intervention consisted of 12 weeks of HCV treatment combined with smoking cessation pharmacotherapy and brief behavioral counseling conducted by a LMSW. The brief behavioral counseling consisted of cognitive behaioral components and was provided by phone and in-person. The intervention followed these 5 phases: increase motivation to quit smoking, quit attempt, maintain short-term abstinence, and lapse and relapse prevention.

Trial Locations (1)

29605

Prisma Health Internal Medicine Clinic, Greenville

All Listed Sponsors
lead

Prisma Health-Upstate

OTHER

NCT05466981 - HCV-Smoking Cessation Study | Biotech Hunter | Biotech Hunter